Goldman Sachs
AHCO icon

Goldman Sachs’s AdaptHealth AHCO Stock Holding History

Goldman Sachs’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.91M Sell
567,503
-562,142
-50% -$6.28M ﹤0.01% 3732
2026
Q1 		$13.4M Buy
1,129,645
+757,864
+204% +$7.76M ﹤0.01% 2806
2025
Q4 		$3.7M Buy
371,781
+77,987
+27% +$745K ﹤0.01% 4025
2025
Q3 		$2.63M Sell
293,794
-130,210
-31% -$1.21M ﹤0.01% 4241
2025
Q2 		$4M Sell
424,004
-147,228
-26% -$1.3M ﹤0.01% 3617
2025
Q1 		$6.19M Buy
571,232
+139,828
+32% +$1.41M ﹤0.01% 3142
2024
Q4 		$4.11M Buy
431,404
+40,660
+10% +$412K ﹤0.01% 3646
2024
Q3 		$4.39M Buy
390,744
+99,151
+34% +$1.05M ﹤0.01% 3466
2024
Q2 		$2.92M Sell
291,593
-92,468
-24% -$940K ﹤0.01% 3635
2024
Q1 		$4.42M Buy
384,061
+37,502
+11% +$319K ﹤0.01% 3204
2023
Q4 		$2.53M Sell
346,559
-499,535
-59% -$3.94M ﹤0.01% 3745
2023
Q3 		$7.7M Buy
846,094
+543,376
+179% +$6.51M ﹤0.01% 2611
2023
Q2 		$3.68M Buy
302,718
+16,614
+6% +$185K ﹤0.01% 3382
2023
Q1 		$3.56M Sell
286,104
-159,052
-36% -$2.93M ﹤0.01% 3378
2022
Q4 		$8.56M Buy
445,156
+267,187
+150% +$5.65M ﹤0.01% 2714
2022
Q3 		$3.34M Buy
177,969
+36,138
+25% +$743K ﹤0.01% 3508
2022
Q2 		$2.56M Sell
141,831
-864
-0.6% -$14K ﹤0.01% 3828
2022
Q1 		$2.29M Buy
142,695
+42,965
+43% +$773K ﹤0.01% 4139
2021
Q4 		$2.44M Buy
99,730
+16,223
+19% +$381K ﹤0.01% 4086
2021
Q3 		$1.95M Sell
83,507
-115,867
-58% -$2.8M ﹤0.01% 4223
2021
Q2 		$5.46M Sell
199,374
-38,626
-16% -$1.1M ﹤0.01% 3264
2021
Q1 		$8.75M Buy
238,000
+162,055
+213% +$5.72M ﹤0.01% 2675
2020
Q4 		$2.85M Buy
75,945
+44,888
+145% +$1.39M ﹤0.01% 3459
2020
Q3 		$677K Buy
+31,057
New +$652K ﹤0.01% 4312
2020
Q2 		– Sell
-36,878
Closed -$590K – 5171
2020
Q1 		$590K Buy
36,878
+18,394
+100% +$260K ﹤0.01% 4114
2019
Q4 		$203K Sell
18,484
-381,516
-95% -$3.79M ﹤0.01% 4890
2019
Q3 		$4.07M Buy
+400,000
New +$4.08M ﹤0.01% 3017

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs's AHCO Position: Q2 2026 in Review

Goldman Sachs reduced its AdaptHealth (AHCO) stake by 50% in Q2 2026, selling an estimated $6.28M and leaving 567,503 shares worth $5.91M. The position accounts for ﹤0.01% of the portfolio, ranked #3732.

Goldman Sachs first reported a position in AHCO in Q3 2019 and has held it in 27 quarters since. The position peaked at $13.4M in Q1 2026. 238 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Goldman Sachs held 567,503 shares of AdaptHealth worth $5.91M as of Q2 2026.
  • Goldman Sachs sold 562,142 AdaptHealth shares in Q2 2026, an estimated $6.28M.
  • AdaptHealth made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3732 holding.
  • Goldman Sachs first reported a position in AdaptHealth in Q3 2019 and has held it in 27 quarters since.
  • Goldman Sachs's AdaptHealth position peaked at $13.4M in Q1 2026.
  • 238 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.